Cervical Cancer - WHO and HRP launch new guideline for screening and treatment of cervical cancer
Can't see this email? View it online
   
  Cervical Cancer  
  The latest cervical cancer news from News Medical  
 HIV, AIDS and Women's HealthHIV, AIDS and Women's Health
 
All women are at risk of contracting HIV, but this risk is significantly elevated in certain groups.
 
   WHO and HRP launch new guideline for screening and treatment of cervical cancerWHO and HRP launch new guideline for screening and treatment of cervical cancer
 
Too many women worldwide – particularly the poorest women – continue to die from cervical cancer; a disease which is both preventable and treatable.
 
   AI screenings of pap smears can detect precursors to cervical cancerAI screenings of pap smears can detect precursors to cervical cancer
 
Using artificial intelligence and mobile digital microscopy, researchers hope to create screening tools that can detect precursors to cervical cancer in women in resource-limited settings.
 
 Adequate levels of antioxidants may reduce HPV infection linked to cervical cancer development
 
Adequate levels of antioxidants may reduce HPV infection linked to cervical cancer developmentA study led by Hui-Yi Lin, Ph.D., Professor of Biostatistics, and a team of researchers at LSU Health New Orleans Schools of Public Health and Medicine has found that adequate levels of five antioxidants may reduce infection with the strains of the human papillomavirus (HPV) associated with cervical cancer development.
 
 
 Parents and young adults urged to get HPV vaccination back on track
 
Parents and young adults urged to get HPV vaccination back on trackSanford Burnham Prebys has joined doctors and scientists across America at National Cancer Institute (NCI)-designated cancer centers and other organizations to issue a joint statement urging the nation's physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.
 
 
 E6-specific inhibitors offer a unique, strategic approach for treating HPV-HNSCC
 
E6-specific inhibitors offer a unique, strategic approach for treating HPV-HNSCCOncotarget published "A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV+ head and neck squamous cell carcinomas" which reported that the incidence of human papillomavirus-positive head and neck squamous cell carcinoma has increased dramatically over the past decades due to an increase in infection of the oral mucosa by HPV.
 
 
 Majority of women do not meet criteria for cervical cancer screening exit
 
Majority of women do not meet criteria for cervical cancer screening exitCurrent guidelines recommend stopping cervical cancer screening at age 65, but women over age 65 make up over one in five new cervical cancer diagnoses, and are twice as likely to die after a cervical cancer diagnosis compared to younger women.